Biogen believes that some of its new drugs, Leqembi, Skyclarys and Zurzuvae, have the potential to revive long-term growth. Can Biogen achieve this goal?

Technology company Cisco is among the groups involved in six virtual power purchase agreements (VPPAs) to secure energy from ...

Shares of Biogen Inc. BIIB slipped 2.42% to $140.19 Wednesday, on what proved to be an all-around mixed trading session for ...

Today, Benzinga 's options scanner spotted 32 uncommon options trades for Biogen. This isn't normal. The overall sentiment of these big-money traders is split between 37% bullish and 31%, bearish. Out ...

We'll catch you up on the Chicago news you need to know. Sign up for the weekly Chicago Catch-Up newsletter. Biogen booked sales of $2.46 billion for the quarter, which is up around 3% from the ...

The stock's fall snapped a seven-day winning streak.